Both in Pharmaceuticals
Oramed Pharmaceuticals vs Inovio Pharmaceuticals
Over the past year ORMP returned +81.1% and INO returned −33.3%; their daily moves had a correlation of 0.00.
ORMP +81.1% INO −33.3%Growth of $1, one year, split-adjusted
| Metric | ORMP | INO |
|---|---|---|
| Price | $4.13 | $1.62 |
| Market cap | $171.8M | $167.5M |
| Today | +3.25% | −2.41% |
| 1 month | −5.7% | +43.4% |
| 6 months | +5.4% | +30.6% |
| Year to date | +44.9% | −6.9% |
| 1 year | +75.0% | −35.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 1.0× | — |
| Price / sales | — | — |
| Net cash | $50.6M | $36.7M |
| Dividend yield | 6.05% | — |
| Volatility (60d) | 36.4% | 261.2% |
| Short % of float | 4.3% | 26.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).